Mississauga, ON -- (SBWIRE) -- 07/05/2013 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “Rafarma Pharmaceuticals Perched to Capitalize on Russian Biotechnology Initiatives.”
Companies mentioned in this article include Rafarma Pharmaceuticals (Pink Sheets:RAFA).
Article Excerpt:
In recent years, Russia has been looking to build its pharmaceutical markets after years of being viewed as lagging other developed nations. President Vladimir Putin has been supportive of developing the market and stated in 2011 that the country should be manufacturing at least 50 percent of its medical equipment requirements domestically by the end of the decade. The market has been growing consistently, expanding more than 17 percent to $15.3 billion in 2009 with Frost & Sullivan forecasting double-digit growth to $37.2 billion in 2016.
Russia-based Rafarma Pharmaceuticals (Pink Sheets:RAFA) is a junior finding itself in the thick of Russian pharmaceutical initiatives. Rafarma is a manufacturer of generic antibiotics and specialty drugs. It also has its own portfolio of products that have been approved by the Ministry of Health of the Russian Federation.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/368/rafarma-pharmaceuticals-perched-to-capitalize-on-russian-biotechnology-initiatives.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp